CEA Test
$36.00
The CEA Test measures carcinoembryonic antigen, a tumor-associated protein that can be elevated in several cancers, most notably colorectal cancer. Its strongest clinical use is not cancer screening, but establishing a baseline after diagnosis, monitoring response to treatment, and watching for possible recurrence over time.
CEA can also rise in noncancerous conditions, including smoking, liver disease, pancreatitis, inflammatory bowel disease, and chronic lung disease. For that reason, the CEA blood test is most useful when interpreted as a trend together with imaging, pathology, symptoms, and other clinical findings.
Description
The CEA blood test measures carcinoembryonic antigen, a tumor-associated protein most commonly used to monitor colorectal cancer and selected other cancers over time.
CEA is most useful when a baseline level is available for comparison. A falling level may accompany treatment response, while a persistent or rising trend may prompt additional evaluation.
CEA is not a stand-alone cancer screening or diagnostic test. Smoking, liver disease, inflammatory bowel disease, pancreatitis, chronic lung disease and other benign conditions can also increase the result.
Labcorp Carcinoembryonic Antigen (CEA) — Test #002139
Cancer Monitoring
Most useful for following a cancer already known to produce CEA, particularly colorectal cancer.
The Trend
Serial results are generally more informative than one isolated CEA measurement.
Not a Screening Test
Normal CEA does not rule out cancer, and elevated CEA does not automatically mean cancer is present.
What Does the CEA Test Measure?
CEA, or carcinoembryonic antigen, is a glycoprotein produced in larger amounts during fetal development. Healthy adults normally have only small circulating amounts.
Some tumors can produce increased CEA. It is most strongly associated with colorectal adenocarcinoma, although elevations may also occur with cancers involving the pancreas, stomach, lung, breast, ovary, liver, thyroid and other tissues.
The test measures the concentration of CEA in serum so the result can be compared with previous and future measurements.
Why Is a CEA Blood Test Ordered?
CEA is primarily useful in patients who have already been diagnosed with a cancer known to produce the marker.
Establish a Baseline
A pretreatment or postsurgical value provides a reference point for later measurements.
Monitor Treatment
Changes in CEA may provide additional information about how a known cancer is responding to therapy.
Follow After Treatment
CEA can be monitored during surveillance after surgery, chemotherapy or other treatment.
Evaluate a Rising Trend
A persistent increase after treatment may prompt imaging or additional diagnostic evaluation.
Labcorp identifies the principal clinical use of CEA as follow-up and treatment management of colorectal carcinoma.
CEA and Colorectal Cancer
Colorectal cancer is one of the best-established applications of CEA testing. When a tumor produces CEA, measuring it before or around treatment makes later results more useful.
- Decreasing CEA may accompany successful treatment.
- Persistent elevation may require additional evaluation.
- A rising trend after treatment may raise concern for recurrence or progression.
CEA Is Not a General Cancer Screening Test
CEA does not have enough sensitivity or specificity to be used alone to screen for cancer.
Cancer Can Be Present With Normal CEA
Not every tumor produces significant CEA, so a normal result cannot exclude cancer.
CEA Can Be Elevated Without Cancer
Smoking and several inflammatory, gastrointestinal, liver, pancreatic and pulmonary conditions may increase CEA.
For colorectal cancer screening, guideline-based methods such as colonoscopy, FIT testing and other established approaches are more appropriate.
What Cancers May Elevate CEA?
- Colon and rectal cancer
- Pancreatic cancer
- Gastric cancer
- Lung cancer
- Breast cancer
- Ovarian cancer
- Liver cancer
- Thyroid cancer
Not every tumor within these categories produces CEA. This is why a patient's own baseline and subsequent trend are often more useful than comparison with a population reference range alone.
What Else Can Cause Elevated CEA?
An elevated CEA result does not automatically indicate cancer or cancer progression.
Smoking & Lung Conditions
- Cigarette smoking
- Emphysema
- Chronic pulmonary inflammation
Gastrointestinal & Liver Conditions
- Cirrhosis
- Chronic hepatitis
- Pancreatitis
- Crohn's disease
- Ulcerative colitis
Mild to moderate elevations may occur in benign disease involving the intestine, pancreas, liver and lungs.
CEA and Smoking
Smoking is particularly important when interpreting a CEA result. Smokers frequently have somewhat higher baseline levels than nonsmokers even in the absence of cancer.
Current smoking status should therefore be documented. If CEA is followed over time, major changes in smoking behavior should also be considered when interpreting the trend.
CEA, Inflammation and the Broader Clinical Picture
CEA is not an inflammation test, but inflammatory conditions can sometimes increase the result.
When a modest elevation is unexplained, the broader clinical assessment may consider:
- Gastrointestinal inflammation
- Liver dysfunction
- Pancreatic inflammation
- Chronic pulmonary inflammation
- Smoking-related tissue injury
Depending on the clinical situation, additional testing may include CBC, CMP, liver enzymes, ferritin, hs-CRP, inflammatory markers or gastrointestinal evaluation.
CEA for Monitoring Treatment Response
When CEA was elevated before treatment, repeat measurements can provide another way to follow the clinical course.
A falling CEA trend may be reassuring when it parallels favorable imaging and clinical findings. A persistent or rising level may prompt closer evaluation, but CEA should never be used alone to determine whether treatment is succeeding or failing.
Why Consistent Testing Matters
Different laboratory methods can produce somewhat different numerical values. When CEA is being followed serially, using the same laboratory and assay method improves comparability.
Labcorp also offers a dedicated CEA Serial Monitor — Test #480095 for patients undergoing repeated monitoring, while Test #002139 is the standard individual CEA measurement.
CEA Reference Range
Labcorp currently reports a general reference interval of approximately 0–4.7 ng/mL, with smoking status affecting interpretation.
These values should not be interpreted as a simple cancer-versus-no-cancer cutoff.
What Can the CEA Test Help Determine?
- What is the current serum CEA concentration?
- Was CEA elevated before or after treatment?
- Is the value decreasing during therapy?
- Has CEA begun increasing after previously falling?
- Is a persistent trend present that may warrant further evaluation?
- Could smoking or benign inflammatory disease be contributing?
- Should imaging or cancer-specific follow-up be considered?
Commonly Ordered With CEA
CBC & CMP
Useful for evaluating anemia, blood-cell abnormalities, liver function, kidney function, electrolytes and general metabolic status.
Liver Testing
Relevant because hepatic disease may influence CEA and because the liver is commonly evaluated during cancer surveillance.
Inflammatory Markers
Tests such as hs-CRP may provide additional information when systemic inflammatory burden is also being investigated.
Imaging & Cancer-Specific Testing
Imaging, colonoscopy and other tumor-specific tests are often considerably more important than CEA alone when recurrence or progression is suspected.
Before Your CEA Blood Test
- Serum blood test performed through Labcorp
- Labcorp Carcinoembryonic Antigen (CEA) #002139
- No fasting is generally required
- Tell your clinician if you currently smoke or recently stopped
- Discuss known liver, pancreatic, intestinal or pulmonary inflammatory conditions
- Use the same laboratory when possible for serial monitoring
- Do not change cancer treatment or prescription medication based solely on a CEA result
How the CEA Test Works
Frequently Asked Questions
Can a CEA test detect cancer?
CEA can be elevated in several cancers, but it cannot reliably diagnose or screen for cancer by itself. Some cancers produce little or no CEA, while smoking and several benign conditions can elevate it.
What is CEA mainly used for?
Its strongest use is monitoring patients who have already been diagnosed with a cancer known to produce CEA, particularly colorectal cancer.
Does a high CEA mean cancer has returned?
Not necessarily. A rising CEA after treatment may require additional evaluation, but smoking, liver disease, pancreatitis, inflammatory bowel disease and chronic lung disease can also increase the result.
Can CEA be normal even when cancer is present?
Yes. Not every cancer produces significant CEA, so a normal value cannot rule out cancer or recurrence.
Why is CEA particularly useful in colorectal cancer?
Colorectal adenocarcinoma is one of the cancers most commonly associated with increased CEA production. When CEA is elevated at baseline, subsequent changes can provide useful information during treatment and surveillance.
Does smoking raise CEA?
Yes. Smokers commonly have somewhat higher baseline CEA levels than nonsmokers, so smoking status should be considered when interpreting the result.
Should CEA be used for routine cancer screening?
No. CEA does not have adequate sensitivity or specificity for general cancer screening. Screening should follow established recommendations based on age, risk, family history and cancer type.
Why should repeat CEA testing use the same laboratory?
Different assay methods may produce somewhat different values. Using the same laboratory improves the reliability of serial comparisons.